Clinical Trial Detail

NCT ID NCT03472560
Title A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Pfizer
Indications

non-small cell lung carcinoma

transitional cell carcinoma

Therapies

Avelumab + Axitinib

Age Groups: adult senior

Additional content available in CKB BOOST